Maritime Service
With the recently proposed FSMA ruling set forth by the FDA, Deltatrak, Inc. is poised to establish itself within the food industry as a leading cold chain monitoring and solutions-based company. DeltaTrak’s contamination prevention tools and monitoring technology will help handlers, suppliers, and distributors comply with the Sanitary Transportation of Human and Animal Food Rule's strict guidelines and food safety standards.
These new mandates will greatly affect the mode of operation for all growers, processors, distributors, transporters, and importers. Facilities and processors which may have maintained a lenient approach to safety standards in the past, will now have to adhere to FSMA guidelines to guard against contamination. It will ultimately become critically necessary to employ meticulous temperature monitoring procedures within the food industry. Using an HACCP (Hazard Analysis and Critical Control Points)-based approach as a means to enhance food safety is the surest way to prevent contamination and prevent adulteration of perishable products.
For a detailed guide to food and sanitation transportation regulations, visit: 1.usa.gov/1ncSD6A.
The FDA will now have authority to take immediate action if contamination is suspected. Michael R. Taylor, FDA’s Deputy Commissioner for Foods and Veterinary Medicine, recently gave an ultimatum to all cold chain industry suppliers, handlers, and distributors. In his blog dated Jan. 31, 2014 titled, ‘Keeping Foods Safe During Transport’ Taylor says, “We can suspend the registration of a facility if the food it produces, packs, or stores presents a serious health hazard. By using these tools now, we’re practicing what we preach as we plan for the future.”
DeltaTrak, Inc. offers products which help to mitigate any food safety risks. For all those impacted by FSMA’s Sanitary Transportation Ruling, DeltaTrak’s products will offer viable application technology solutions focused towards ensuring compliance to this new ruling once it is implemented.
As of today, the FDA has extended its comment period for this proposed rule. All comments are to be submitted by July 30, 2014.
